ADRB3 and heart failure: The benefits of indirect β3-AR inhibition may partly explain why carvedilol is more effective than metoprolol in improving haemodynamics and cardiac remodelling in HF, as demonstrated in a rat model [251], as well as the improved survival observed in patients with heart failure in the Carvedilol Or Metoprolol European Trial (COMET) [252].